List of Tables
Table 1. Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Osteoarthritis Pain Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Osteoarthritis Pain Drugs Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Osteoarthritis Pain Drugs Sales by Region (2020-2025) & (K Units)
Table 5. Global Osteoarthritis Pain Drugs Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Osteoarthritis Pain Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Osteoarthritis Pain Drugs Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Osteoarthritis Pain Drugs Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Osteoarthritis Pain Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Osteoarthritis Pain Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Osteoarthritis Pain Drugs Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Osteoarthritis Pain Drugs Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Osteoarthritis Pain Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Osteoarthritis Pain Drugs Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Osteoarthritis Pain Drugs Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Osteoarthritis Pain Drugs Sales Share by Manufacturer (2020-2025)
Table 18. Osteoarthritis Pain Drugs Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Osteoarthritis Pain Drugs Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Osteoarthritis Pain Drugs Price (2020-2025) & (USD/Unit)
Table 21. Ranking of Global Top Osteoarthritis Pain Drugs Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Osteoarthritis Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Osteoarthritis Pain Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2024)
Table 24. Osteoarthritis Pain Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Osteoarthritis Pain Drugs Market
Table 26. Manufacturers Osteoarthritis Pain Drugs Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Pfizer Company Information
Table 29. Pfizer Description and Business Overview
Table 30. Pfizer Osteoarthritis Pain Drugs Product
Table 31. Pfizer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 32. Pfizer Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 33. Pfizer Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 34. Pfizer Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 35. Pfizer Recent Developments
Table 36. Bayer Company Information
Table 37. Bayer Description and Business Overview
Table 38. Bayer Osteoarthritis Pain Drugs Product
Table 39. Bayer Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 40. Bayer Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 41. Bayer Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 42. Bayer Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 43. Bayer Recent Developments
Table 44. SK Chemicals Company Information
Table 45. SK Chemicals Description and Business Overview
Table 46. SK Chemicals Osteoarthritis Pain Drugs Product
Table 47. SK Chemicals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 48. SK Chemicals Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 49. SK Chemicals Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 50. SK Chemicals Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 51. SK Chemicals Recent Developments
Table 52. GSK Company Information
Table 53. GSK Description and Business Overview
Table 54. GSK Osteoarthritis Pain Drugs Product
Table 55. GSK Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. GSK Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 57. GSK Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 58. GSK Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 59. GSK Recent Developments
Table 60. Sanofi Company Information
Table 61. Sanofi Description and Business Overview
Table 62. Sanofi Osteoarthritis Pain Drugs Product
Table 63. Sanofi Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Sanofi Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 65. Sanofi Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 66. Sanofi Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 67. Sanofi Recent Developments
Table 68. Crystal Genomics Company Information
Table 69. Crystal Genomics Description and Business Overview
Table 70. Crystal Genomics Osteoarthritis Pain Drugs Product
Table 71. Crystal Genomics Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Crystal Genomics Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 73. Crystal Genomics Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 74. Crystal Genomics Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 75. Crystal Genomics Recent Developments
Table 76. Johnson & Johnson Company Information
Table 77. Johnson & Johnson Description and Business Overview
Table 78. Johnson & Johnson Osteoarthritis Pain Drugs Product
Table 79. Johnson & Johnson Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Johnson & Johnson Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 81. Johnson & Johnson Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 82. Johnson & Johnson Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 83. Johnson & Johnson Recent Developments
Table 84. Sino Biopharmaceutical Company Information
Table 85. Sino Biopharmaceutical Description and Business Overview
Table 86. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product
Table 87. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Sino Biopharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 89. Sino Biopharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 90. Sino Biopharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 91. Sino Biopharmaceutical Recent Developments
Table 92. Haohai Biological Company Information
Table 93. Haohai Biological Description and Business Overview
Table 94. Haohai Biological Osteoarthritis Pain Drugs Product
Table 95. Haohai Biological Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Haohai Biological Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 97. Haohai Biological Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 98. Haohai Biological Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 99. Haohai Biological Recent Developments
Table 100. Zhejiang Chengyi Pharmaceutical Company Information
Table 101. Zhejiang Chengyi Pharmaceutical Description and Business Overview
Table 102. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product
Table 103. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Zhejiang Chengyi Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 105. Zhejiang Chengyi Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 106. Zhejiang Chengyi Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 107. Zhejiang Chengyi Pharmaceutical Recent Developments
Table 108. Freda Company Information
Table 109. Freda Description and Business Overview
Table 110. Freda Osteoarthritis Pain Drugs Product
Table 111. Freda Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Freda Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 113. Freda Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 114. Freda Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 115. Freda Recent Developments
Table 116. Bright Future Company Information
Table 117. Bright Future Description and Business Overview
Table 118. Bright Future Osteoarthritis Pain Drugs Product
Table 119. Bright Future Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Bright Future Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 121. Bright Future Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 122. Bright Future Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 123. Bright Future Recent Developments
Table 124. Jingfeng Pharmaceutical Company Information
Table 125. Jingfeng Pharmaceutical Description and Business Overview
Table 126. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product
Table 127. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Jingfeng Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 129. Jingfeng Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 130. Jingfeng Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 131. Jingfeng Pharmaceutical Recent Developments
Table 132. Chugai Pharmaceutical Company Information
Table 133. Chugai Pharmaceutical Description and Business Overview
Table 134. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product
Table 135. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Chugai Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 137. Chugai Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 138. Chugai Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 139. Chugai Pharmaceutical Recent Developments
Table 140. Mikasa Seiyaku Company Information
Table 141. Mikasa Seiyaku Description and Business Overview
Table 142. Mikasa Seiyaku Osteoarthritis Pain Drugs Product
Table 143. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 144. Mikasa Seiyaku Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 145. Mikasa Seiyaku Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 146. Mikasa Seiyaku Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 147. Mikasa Seiyaku Recent Developments
Table 148. Taisho Pharmaceutical Company Information
Table 149. Taisho Pharmaceutical Description and Business Overview
Table 150. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product
Table 151. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Taisho Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 153. Taisho Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 154. Taisho Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 155. Taisho Pharmaceutical Recent Developments
Table 156. Seikagaku Corporation Company Information
Table 157. Seikagaku Corporation Description and Business Overview
Table 158. Seikagaku Corporation Osteoarthritis Pain Drugs Product
Table 159. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Seikagaku Corporation Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 161. Seikagaku Corporation Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 162. Seikagaku Corporation Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 163. Seikagaku Corporation Recent Developments
Table 164. GlaxoSmithKline Company Information
Table 165. GlaxoSmithKline Description and Business Overview
Table 166. GlaxoSmithKline Osteoarthritis Pain Drugs Product
Table 167. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. GlaxoSmithKline Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 169. GlaxoSmithKline Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 170. GlaxoSmithKline Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 171. GlaxoSmithKline Recent Developments
Table 172. Eli Lilly Company Information
Table 173. Eli Lilly Description and Business Overview
Table 174. Eli Lilly Osteoarthritis Pain Drugs Product
Table 175. Eli Lilly Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 176. Eli Lilly Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 177. Eli Lilly Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 178. Eli Lilly Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 179. Eli Lilly Recent Developments
Table 180. Novartis Company Information
Table 181. Novartis Description and Business Overview
Table 182. Novartis Osteoarthritis Pain Drugs Product
Table 183. Novartis Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 184. Novartis Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 185. Novartis Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 186. Novartis Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 187. Novartis Recent Developments
Table 188. Horizon Pharma Company Information
Table 189. Horizon Pharma Description and Business Overview
Table 190. Horizon Pharma Osteoarthritis Pain Drugs Product
Table 191. Horizon Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 192. Horizon Pharma Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 193. Horizon Pharma Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 194. Horizon Pharma Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 195. Horizon Pharma Recent Developments
Table 196. Abbott Company Information
Table 197. Abbott Description and Business Overview
Table 198. Abbott Osteoarthritis Pain Drugs Product
Table 199. Abbott Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 200. Abbott Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 201. Abbott Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 202. Abbott Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 203. Abbott Recent Developments
Table 204. Mylan Company Information
Table 205. Mylan Description and Business Overview
Table 206. Mylan Osteoarthritis Pain Drugs Product
Table 207. Mylan Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 208. Mylan Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 209. Mylan Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 210. Mylan Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 211. Mylan Recent Developments
Table 212. Daiichi Sankyo Company Information
Table 213. Daiichi Sankyo Description and Business Overview
Table 214. Daiichi Sankyo Osteoarthritis Pain Drugs Product
Table 215. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 216. Daiichi Sankyo Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 217. Daiichi Sankyo Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 218. Daiichi Sankyo Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 219. Daiichi Sankyo Recent Developments
Table 220. TEVA Company Information
Table 221. TEVA Description and Business Overview
Table 222. TEVA Osteoarthritis Pain Drugs Product
Table 223. TEVA Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 224. TEVA Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 225. TEVA Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 226. TEVA Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 227. TEVA Recent Developments
Table 228. Almatica Pharma Company Information
Table 229. Almatica Pharma Description and Business Overview
Table 230. Almatica Pharma Osteoarthritis Pain Drugs Product
Table 231. Almatica Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 232. Almatica Pharma Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 233. Almatica Pharma Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 234. Almatica Pharma Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 235. Almatica Pharma Recent Developments
Table 236. Astellas Pharma Company Information
Table 237. Astellas Pharma Description and Business Overview
Table 238. Astellas Pharma Osteoarthritis Pain Drugs Product
Table 239. Astellas Pharma Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 240. Astellas Pharma Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 241. Astellas Pharma Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 242. Astellas Pharma Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 243. Astellas Pharma Recent Developments
Table 244. Tide Pharmaceutical Company Information
Table 245. Tide Pharmaceutical Description and Business Overview
Table 246. Tide Pharmaceutical Osteoarthritis Pain Drugs Product
Table 247. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 248. Tide Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 249. Tide Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 250. Tide Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 251. Tide Pharmaceutical Recent Developments
Table 252. Iroko Pharmaceuticals Company Information
Table 253. Iroko Pharmaceuticals Description and Business Overview
Table 254. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product
Table 255. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 256. Iroko Pharmaceuticals Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 257. Iroko Pharmaceuticals Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 258. Iroko Pharmaceuticals Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 259. Iroko Pharmaceuticals Recent Developments
Table 260. Hengrui Pharmaceutical Company Information
Table 261. Hengrui Pharmaceutical Description and Business Overview
Table 262. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product
Table 263. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 264. Hengrui Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Product in 2024
Table 265. Hengrui Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Application in 2024
Table 266. Hengrui Pharmaceutical Sales Proportion of Osteoarthritis Pain Drugs by Geographic Area in 2024
Table 267. Hengrui Pharmaceutical Recent Developments
Table 268. North America Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K Units)
Table 269. North America Osteoarthritis Pain Drugs Sales by Country (2026-2031) & (K Units)
Table 270. North America Osteoarthritis Pain Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 271. North America Osteoarthritis Pain Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 272. North America Osteoarthritis Pain Drugs Sales by Type (2020-2025) & (K Units)
Table 273. North America Osteoarthritis Pain Drugs Sales by Application (2020-2025) & (K Units)
Table 274. Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2020-2025) & (K Units)
Table 275. Asia-Pacific Osteoarthritis Pain Drugs Sales by Region (2026-2031) & (K Units)
Table 276. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 277. Asia-Pacific Osteoarthritis Pain Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 278. Asia-Pacific Osteoarthritis Pain Drugs Sales by Type (2020-2025) & (K Units)
Table 279. Asia-Pacific Osteoarthritis Pain Drugs Sales by Application (2020-2025) & (K Units)
Table 280. Europe Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K Units)
Table 281. Europe Osteoarthritis Pain Drugs Sales by Country (2026-2031) & (K Units)
Table 282. Europe Osteoarthritis Pain Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 283. Europe Osteoarthritis Pain Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 284. Europe Osteoarthritis Pain Drugs Sales by Type (2020-2025) & (K Units)
Table 285. Europe Osteoarthritis Pain Drugs Sales by Application (2020-2025) & (K Units)
Table 286. Latin America Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K Units)
Table 287. Latin America Osteoarthritis Pain Drugs Sales by Country (2026-2031) & (K Units)
Table 288. Latin America Osteoarthritis Pain Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 289. Latin America Osteoarthritis Pain Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 290. Latin America Osteoarthritis Pain Drugs Sales by Type (2020-2025) & (K Units)
Table 291. Latin America Osteoarthritis Pain Drugs Sales by Application (2020-2025) & (K Units)
Table 292. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K Units)
Table 293. Middle East and Africa Osteoarthritis Pain Drugs Sales by Country (2026-2031) & (K Units)
Table 294. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 295. Middle East and Africa Osteoarthritis Pain Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 296. Middle East and Africa Osteoarthritis Pain Drugs Sales by Type (2020-2025) & (K Units)
Table 297. Middle East and Africa Osteoarthritis Pain Drugs Sales by Application (2020-2025) & (K Units)
Table 298. Osteoarthritis Pain Drugs Key Raw Materials, Industry Status and Trend
Table 299. Osteoarthritis Pain Drugs Key Raw Materials and Upstream Suppliers
Table 300. Osteoarthritis Pain Drugs Clients Status and Trend
Table 301. Osteoarthritis Pain Drugs Typical Clients
Table 302. Osteoarthritis Pain Drugs Distributors
Table 303. Osteoarthritis Pain Drugs Market Trends
Table 304. Osteoarthritis Pain Drugs Market Drivers
Table 305. Osteoarthritis Pain Drugs Market Challenges
Table 306. Osteoarthritis Pain Drugs Market Restraints
Table 307. Research Programs/Design for This Report
Table 308. Key Data Information from Secondary Sources
Table 309. Key Data Information from Primary Sources
Table 310. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Osteoarthritis Pain Drugs Product Picture
Figure 2. Global Osteoarthritis Pain Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Osteoarthritis Pain Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Osteoarthritis Pain Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Osteoarthritis Pain Drugs Sales Market Share by Application in 2024 & 2031
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Osteoarthritis Pain Drugs Report Years Considered
Figure 12. Global Osteoarthritis Pain Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Osteoarthritis Pain Drugs Market Size 2020-2031 (US$ Million)
Figure 14. Global Osteoarthritis Pain Drugs Sales 2020-2031 (K Units)
Figure 15. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Region (2020-2031)
Figure 16. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2020-2031)
Figure 17. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2020-2031)
Figure 18. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Osteoarthritis Pain Drugs Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
Figure 20. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Application (2020-2031)
Figure 21. Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Application (2020-2031)
Figure 22. Osteoarthritis Pain Drugs Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
Figure 23. Oral of Osteoarthritis Pain Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 24. Injection of Osteoarthritis Pain Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 25. External of Osteoarthritis Pain Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 26. Global Osteoarthritis Pain Drugs Sales Share by Manufacturer in 2024
Figure 27. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 28. Oral Market Sales Proportion by Manufacturer in 2024
Figure 29. Injection Market Sales Proportion by Manufacturer in 2024
Figure 30. External Market Sales Proportion by Manufacturer in 2024
Figure 31. North America Osteoarthritis Pain Drugs Revenue 2020-2031 (US$ Million)
Figure 32. North America Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
Figure 33. North America Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Figure 34. Asia-Pacific Osteoarthritis Pain Drugs Revenue 2020-2031 (US$ Million)
Figure 35. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Region (2020-2031)
Figure 36. Asia-Pacific Osteoarthritis Pain Drugs Revenue Market Share by Region (2020-2031)
Figure 37. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
Figure 38. Asia-Pacific Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Figure 39. Europe Osteoarthritis Pain Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Europe Osteoarthritis Pain Drugs Sales Market Share by Country (2020-2031)
Figure 41. Europe Osteoarthritis Pain Drugs Revenue Market Share by Country (2020-2031)
Figure 42. Europe Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
Figure 43. Europe Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Figure 44. Latin America Osteoarthritis Pain Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Latin America Osteoarthritis Pain Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Osteoarthritis Pain Drugs Revenue Market Share by Country (2020-2025)
Figure 47. Latin America Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
Figure 48. Latin America Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Figure 49. Middle East and Africa Osteoarthritis Pain Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Osteoarthritis Pain Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
Figure 53. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Figure 54. Osteoarthritis Pain Drugs Supply Chain (Upstream and Downstream Market)
Figure 55. Global Production Market Share of Osteoarthritis Pain Drugs Raw Materials by Region in 2024
Figure 56. Osteoarthritis Pain Drugs Distribution Channels
Figure 57. Global Osteoarthritis Pain Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 58. Global Osteoarthritis Pain Drugs Percentage 2020-2031: Online Sales VS Offline Sales
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
